(Thanks to Atid-EDI) Israel’s D-Pharm Ltd has announced positive results for its treatments for human African trypanosomiasis (sleeping sickness) and malaria. D-Pharm’s Membrane Active Chelators regulate metal ions in the cells that are disrupted by these parasitic-born diseases.
http://www.dpharm.com/news.asp?year=2013&type=0&mode=1&id=141